Non-Human Lentiviral Models of the Neurological Complications of AIDS (R01)

The summary for the Non-Human Lentiviral Models of the Neurological Complications of AIDS (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Non-Human Lentiviral Models of the Neurological Complications of AIDS (R01): -Purpose. The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH) invite research grant applications aimed at developing non-human lentiviral in vivo model systems for study of the neurologic complications of AIDS, with or without a history of drug use. Recent advances in the development of the SIV model system highlight the power of animal model systems for study of the mechanisms underlying the pathology associated with lentiviral infection in the nervous system. These models will be key for developing therapeutic approaches for the treatment of patients suffering from NeuroAIDS and for understanding the basic biology of infection with HIV/AIDS. -Mechanism of Support. This funding opportunity will use the NIH Research Project (R01) award mechanism, but will be run in parallel with two program announcements of identical scientific scope (PAS-06-275 and PAS-06-276) that will utilize the small research grant (R03) and exploratory/developmental grant (R21) mechanisms, respectively. -Funds Available and Anticipated Number of Awards. The participating organizations intend to commit a total of $2,150,000 to this PAS for payment of applications responsive to this announcement and the two parallel announcements (see above). Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.